期刊文献+

胡桃醌通过PI3K/AKT途径促进前列腺癌LNCaP细胞氧化应激 被引量:6

Juglone promote oxidative stress through PI3K/AKT pathway in prostate cancer cell
下载PDF
导出
摘要 目的探讨胡桃醌对人前列腺癌LNCa P细胞的杀伤活性与其诱导氧化应激反应的相关性及机制。方法采用0、6.25、12.5、25、50和100μmol/L胡桃醌作用前列腺癌LNCa P细胞,MTT法检测不同剂量胡桃醌对LNCa P细胞生长抑制影响;胡桃醌联合抗氧化剂NAC作用细胞后,DCFHDA作为荧光探针,用荧光酶标法检测活性氧(ROS);胡桃醌联合PI3K/AKT通路抑制LY294002作用细胞后,Western blot法检测p-AKT、AKT和Nrf2蛋白表达变化。结果与阴性对照组比较,胡桃醌浓度在12.5μmol/L或以上显著抑制前列腺癌细胞生长(P<0.05,P<0.01)。胡桃醌能够促进细胞ROS含量(P<0.01);胡桃醌联合抗氧化剂N-乙酰半胱氨酸(NAC)导致ROS含量下降(P<0.05),细胞存活率升高(P<0.01)。胡桃醌抑制p-AKT的表达,NAC能够恢复胡桃醌抑制的p-AKT表达。胡桃醌能够抑制细胞核Nrf2的表达,与PI3K/AKT抑制剂LY294002联合使用进一步抑制了Nrf2的表达。结论胡桃醌能够抑制前列腺癌LNCa P细胞增殖,作用的机制可能与促进ROS产生从而抑制PI3K/AKT途径,导致Nrf2表达下降有密切关系。 Objective To investigate the killing activity of Juglone in human prostate cancer LNCaP cell and the correlation between oxidative stress and its mechanism. Methods LNCaP cells were treated with 0, 6. 25, 12. 5, 25, 50 and 100 μmol/L Juglone. MTT assay was used to determine the growth of LNCaP cells treated with different concentrations of Juglone. Reactive oxygen species (ROS) was detected using fluorescence microplate reader with 2' ,7'-dichlorofluoresceindiacetate (DCFH-DA) as fluorescent probe after treating LNCaP cells with Juglone and NAC. The expression levels of p-AKT, AKT and Nrf2 proteins were examined in LNCaP cells that were cultured with Juglone and LY294002 using Western blot. Results Compared with the control group, the concentration of Juglonein more than 12.5 μmol/L could significantly inhibit the growth of LNCaP cells ( P 〈 0.05, P 〈 0. 01 ). The ROS levels were increased in Juglone group compared with control group (P 〈0.01 ). Compared with the Juglone group, ROS levels was inhibited (P 〈 0. 05 ) and increased the cell proliferation rates by combination use with NAC (P 〈 0.01 ). Juglone inhibited expression of p-AKT and addition of NAC resorted the Juglone inhibition of p-AKT expression. Nrf2 expression were down-regulated in cell nucleus treated with Juglone and then inhibition of PI3K/AKT with LY294002 augmented Juglone-mediated function. Conclusion Juglone could significantly in- hibit the growth of LNCaP cells and the effect may be related to promoted ROS levels through PI3K/AKT pathway and then inhibit the Nrf2 expression.
出处 《安徽医科大学学报》 CAS 北大核心 2018年第1期63-66,共4页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:81202031) 吉林省教育厅"十二五"科学技术研究项目(编号:吉教科合字[2014]第360号)
关键词 胡桃醌 前列腺癌 ROS PI3K/AKT Nrf2 生长抑制 Juglone prostate cancer reactive oxygen species PI3K/AKT Nrf2 growth inhibition
  • 相关文献

参考文献2

二级参考文献17

  • 1Lu KP, Hanes SD, Hunter T,et al. A human peptidyl-pm-lyl isomerase essential for regulation of mitosis[ J]. Nature,1996,380:544-547.
  • 2He J,Zhou F, Shao K, et al. Overexpression of Pinl innon-small cell lung cancer ( NSCLC) and its correlationwith lymph node metastases[ J ] . Lung Cancer, 2007, 56:51 -58.
  • 3Tan XG, Zhou F,Wan JT, et al. PIN1 expression contrib-utes to lung cancer prognosis and carcinogenesis [ J ]. Canc-er Biology & Therapy, 2010, 9:1 -9.
  • 4Liao Y, Wei Y,Zhou X,et al. Peptidyl-prolyl cis/transisomerase PIN1 is critical for the regulation of PKB/AKTstability and activation phosphorylation [ J ]. Oncogene,2009,28:2436 - 2445.
  • 5Mathur R, Chandna S, KapoorV PN,et al. Peptidyl prolylIsomerase, Pinl is a potential target for enhancing the thera-peutic efficacy of etoposide [ J ]. Curr Cancer Drug Targets,2011,ll:380-392.
  • 6Catanzaro J, Wei XZ, Pinpointing Pinl in non-small celllung carcinoma[ J]. Cancer Biol & Ther, 2010,9:1 -2.
  • 7Lu KP, Zhou XZ. The prolyl isomerase PIN1 :a pivotal newtwist in phosphorylation signalling and disease[ J] . Nat RevMol Cell Biol, 2007, 8:904 -916.
  • 8Mathur R, Suman S, Beaume N, et al. Interaction andstructural modification of topoisomerase Ilaipha by peptidylprolyl isomerase,pinl : an in silico study [ J ]. ProteinPept Lett, 2010,17:151 -163.
  • 9Shen MM,Abate-Shen C.Molecular genetics of prostate cancer:new prospects for old challenges[J].Genes Dev,2010,24(18):1967-2000.
  • 10Ryo A,Liou YC,Lu KP,et al.Proly isomerase Pin1:a catalyst for oncogenesis and a potential therapeutic target in cancer [J].J Cell Sci,2003,116(5):773-783.

共引文献15

同被引文献68

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部